Sheir Khaled Z, Elhalwagy Samer M, Abo-Elghar Mohamed E, Ismail Amani M, Elsawy Essam, El-Diasty Tarek A, Dawaba Mohamed E, Eraky Ibrahim A, El-Kenawy Mahmoud R
Department of Urology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
BJU Int. 2008 Jun;101(11):1420-6. doi: 10.1111/j.1464-410X.2007.07357.x. Epub 2007 Dec 5.
To asses the efficacy and safety of bidirectional synchronous twin-pulse extracorporeal shock wave lithotripsy (ESWL) compared with standard ESWL.
Between March 2003 and December 2006, 240 patients with a radio-opaque single renal stone of <or=25 mm were randomized to treatment either by the Twinheads (TH) lithotripter (FMD, Lorton, Virginia, USA) or the Dornier Lithotripter S (DLS, Dornier MedTech Europe GmbH, Germering, Germany). Before and after ESWL, urinary N-acetyl-B-glucosaminidase (NAG) levels were assessed and patients were evaluated with dynamic MRI. The efficacy and complications were compared, with success defined as no residual fragments.
For stones of >10 mm the rate for the failure of disintegration was 13.3% for the DLS vs 1.4% for the TH (P = 0.009). For stones of <or=10 mm the stone-free rate was 74.4% for the TH vs 67.7% for the DLS (P = 0.6), while for stones of >10 mm it was 78.1% and 66.7%, respectively (P = 0.14). The median (range) number of sessions in both groups was 2 (1-5). After ESWL urinary NAG levels were increased significantly in both groups; in the TH group it declined below the level before ESWL after 2 days, while in the DLS group it remained high after 7 days. In the DLS group four patients developed subcapsular or parenchymal haematoma after ESWL, vs none in the TH group. There was loss of corticomedullary differentiation after ESWL in three patients in the DLS group and only one in the TH group. In the DLS group there was a statistically significantly decrease in bilateral renal perfusion after ESWL, but no changes in the TH group.
Synchronous twin-pulse ESWL has clinical advantages over standard ESWL in terms of safety and efficacy.
评估双向同步双脉冲体外冲击波碎石术(ESWL)与标准ESWL相比的疗效和安全性。
2003年3月至2006年12月期间,将240例不透X线的单个肾结石直径≤25mm的患者随机分为两组,分别采用双探头(TH)碎石机(美国弗吉尼亚州洛顿市FMD公司)或多尼尔碎石机S(DLS,德国盖默灵市多尼尔医疗技术欧洲有限公司)进行治疗。ESWL治疗前后,评估尿N-乙酰-β-葡萄糖苷酶(NAG)水平,并对患者进行动态磁共振成像(MRI)评估。比较疗效和并发症,成功定义为无残留碎片。
对于直径>10mm的结石,DLS组的碎石失败率为13.3%,而TH组为1.4%(P = 0.009)。对于直径≤10mm的结石,TH组的结石清除率为74.4%,DLS组为67.7%(P = 0.6);对于直径>10mm的结石,两组的结石清除率分别为78.1%和66.7%(P = 0.14)。两组的中位(范围)治疗次数均为2次(1 - 5次)。ESWL治疗后,两组患者的尿NAG水平均显著升高;TH组在2天后降至ESWL治疗前水平以下,而DLS组在7天后仍保持较高水平。DLS组有4例患者在ESWL治疗后出现肾包膜下或实质内血肿,而TH组无此情况。DLS组有3例患者在ESWL治疗后出现肾皮质髓质分界消失,TH组仅有1例。DLS组在ESWL治疗后双侧肾灌注有统计学显著下降,而TH组无变化。
同步双脉冲ESWL在安全性和疗效方面比标准ESWL具有临床优势。